Toggle light / dark theme

How Intestinal Aging Encourages Harmful Bacteria

In Aging Cell, researchers have elucidated the relationship between intestinal aging and age-related changes to the gut microbiome.

Two interdependent biologies

The human gut works through the interaction of two entirely different sets of cells. The first is the body’s actual cells, including the intestinal barrier between the gut and the rest of the body, various types of ordinary immune cells, and Peyer’s patches with follicle-associated epithelium (FAE) areas that contain microfold cells (M cells), which perform crucial immunoregulatory tasks [1]. The second is the gut microbiome, the various types of bacteria that help us digest food.

This tiny grain-of-rice sensor gives robots a new sense and changes what delicate tools can detect

Researchers have developed a sensor about the size of a grain of rice that can measure forces and twisting motions in all directions using light instead of traditional electronics. The new sensor could help robotic tools and medical devices “feel” what they are touching, especially at very small scales.

“Although modern imaging systems can show structures clearly, they do not provide information about physical interaction, such as force or torque, and existing force sensors are often too bulky or complex to fit into miniature tools,” said research team leader Jianlong Yang from Shanghai Jiao Tong University in China. “By allowing machines to measure contact force, pressure, shear and twisting, our technology could make it possible for robots to detect unsafe contact early and adjust their actions in real time, especially in small and sensitive environments.”

In Optica journal, the researchers describe their new sensor, which measures just 1.7 millimeters and uses a single optical signal to measure forces and torques in all directions at once. Proof-of-concept tests showed that the sensor can detect stiffness variations and locate hidden structures in models that mimic a tumor embedded in tissue.

Lab-grown diamond device could change how radiation doses are measured

A team led by researchers from Tokyo Metropolitan University, in collaboration with Tohoku University and Orbray Co., Ltd., using heteroepitaxial diamond materials developed by Orbray, have shown that lab-grown diamonds might realize a radiation dosimeter compatible with both medical diagnosis and radiation therapy.

The work is published in the journal Medical Physics.

They demonstrated that a diamond-based dosimeter could accurately measure doses in the same energy range as diagnostic X-rays, with far better sensitivity per volume than conventional detectors. Using the same device for dosimetry during both diagnosis and therapies could enable improved consistency.

Towards a context-aware framework for cellular senescence

From a cellular perspective, senescence has been considered a binary state, wherein cells are either senescent or not. This reductionist notion, often defined as irreversible growth arrest, has guided efforts to identify universal biomarkers and senolytics, but both have consistently eluded us. This outcome is not surprising, given that the biological nature of senescence may not be strictly irreversible; the accumulated evidence suggests that growth arrest can become unstable over time, with cells acquiring alterations, occasionally regaining proliferative capacity, or undergoing partial reprogramming, and exhibiting a heterogeneous spectrum of phenotypes (“senotypes”) influenced by tissue types, stressors, temporal dynamics, and disease states.

How the brain decides which memories belong together could reshape schizophrenia research

Our memories of past events are typically not isolated, but they are linked to other related memories. This ability to establish connections between related memories is highly advantageous, as it helps us to recognize familiar patterns in new situations and make predictions that can inform our decisions.

Researchers at UCLA’s Brain Research Institute recently carried out a study on mice aimed at better understanding how the brain decides what memories are connected and which ones are not. Their paper, published in Nature Neuroscience, pinpoints brain regions that could play a role in the organization of memories into coherent pools of knowledge.

“Our lab has long been interested in understanding how the brain connects related memories,” André F. de Sousa, first author of the paper, told Medical Xpress. “In everyday life, new experiences are rarely processed in isolation. Instead, they are often shaped by what we have learned before. This ability allows us to link related events, build knowledge, and use past experiences to guide future behavior. However, this process needs to be carefully controlled.”

Noninvasive deep brain stimulation technique shows early promise for treating Parkinson’s disease

A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new way to treat motor symptoms in Parkinson’s disease without the need for surgery, according to a pilot study appearing in eBioMedicine. The technique, which uses overlapping electrical currents to selectively target deep brain regions, significantly improved movement in patients compared with a sham treatment when targeting the subthalamic nucleus.

Parkinson’s disease is a progressive neurological disorder that affects movement, often causing tremor, stiffness, and slowed motion. One of the most effective treatments for advanced symptoms is deep brain stimulation (DBS), which involves implanting electrodes into the brain. TIs may be able to achieve a similar effect—targeting the same deep brain structures —but entirely from outside the skull, using carefully calibrated electrical fields delivered through the scalp.

In the randomized, double-blind, crossover study, titled “Transcranial temporal interference stimulation targeting the subthalamic region for motor symptoms in Parkinson’s disease: a pilot, randomised, double-blind, sham-controlled crossover study,” 30 people with early-to mid-stage Parkinson’s disease received a single 20-minute session of individualized TIs targeting the subthalamic region—a key node in the brain’s motor control network—as well as a sham or placebo treatment in a separate session.

Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic

This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.

Rewiring the urge to smoke: How targeted brain stimulation may help people to quit

For many people who smoke, quitting is not just a matter of willpower. It is a tug-of-war in the brain—between the pull of reward and the ability to resist.

A study published in the Journal of Psychiatric Research suggests that shifting that balance may be possible. Using a noninvasive brain stimulation technique called repetitive transcranial magnetic stimulation, or rTMS, researchers at MUSC Hollings Cancer Center found that stimulating a specific brain region that regulates self-control significantly reduced how much people smoked.

/* */